Dispensing of Ivermectin From Veterans Administration Pharmacies During the COVID-19 Pandemic

被引：5

作者：

Becker, Nora V. ^{[1
]}

Seelye, Sarah ^{[2
]}

Chua, Kao-Ping ^{[3
]}

Echevarria, Kelly ^{[4
]}

Conti, Rena M. ^{[5
]}

Prescott, Hallie C. ^{[2
]}

机构：

[1] Univ Michigan, Div Gen Med, Dept Internal Med, Ann Arbor, MI USA

[2] VA Ctr Clin Management Res, Ann Arbor, MI USA

[3] Univ Michigan, Dept Pediat, Ann Arbor, MI USA

[4] Vet Hlth Adm Pharm Benefits Management, San Antonio, TX USA

[5] Boston Univ, Questrom Sch Business, Boston, MA USA

来源：

JAMA NETWORK OPEN | 2023年 / 6卷 / 02期

基金：

美国医疗保健研究与质量局;

关键词：

D O I：

10.1001/jamanetworkopen.2022.54859

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：4

共 6 条

[1]

Centers for Disease Control and Prevention, 2021, Rapid increase in ivermectin prescriptions and reports of severe illness associated with use of products containing ivermectin to prevent or treat COVID-19

[2] US Insurer Spending on Ivermectin Prescriptions for COVID-19 [J].

Chua, Kao-Ping ;

Conti, Rena M. ;

Becker, Nora V. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (06) :584-587

[3]

Popp M, 2021, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD015017.pub2, 10.1002/14651858.CD015017]

[4]

Sales MM, 2005, AM J MANAG CARE, V11, P104

[5]

US Department of Veterans Affairs, 2021, VA FORM ADV IV STROM

[6]

Veterans Health Administration, 2022, VHA DIR 1108 08 VHA

← 1 →